These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3132643

  • 1. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
    Lucas PA, Woodhead JS, Brown RC.
    Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K, Reinhardt D, Grosse-Hohmann E, Keck E.
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D3 metabolites in hypercalcaemic adults after kidney transplantation.
    Lucas PA, Brown RC, Bloodworth L, Woodhead JS.
    Proc Eur Dial Transplant Assoc; 1983 Sep; 20():213-9. PubMed ID: 6318219
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of fibroblast growth factor-23 in chronic kidney disease.
    Westerberg PA, Linde T, Wikström B, Ljunggren O, Stridsberg M, Larsson TE.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3202-7. PubMed ID: 17567652
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC, Lin SH, Yu FC, Chyr SH, Shieh SD.
    Miner Electrolyte Metab; 1995 Nov; 21(6):398-402. PubMed ID: 8592483
    [Abstract] [Full Text] [Related]

  • 11. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS, Coburn JW, Friedman GR, Okamura WH, Massry SG, Norman AW.
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute responses of parathyroid hormone and 1,25 dihydroxyvitamin D3 to unilateral nephrectomy in healthy donors.
    Lucas PA, Brown RC, Woodhead JS.
    Nephrol Dial Transplant; 1986 Jun; 1(3):199-203. PubMed ID: 3110674
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G, Mazzaferro S, Costantini S, Ballanti P, Carrieri MP, Giordano R, Smacchi A, Sardella D, Bonucci E, Taggi F.
    Miner Electrolyte Metab; 1989 Jun; 15(5):295-302. PubMed ID: 2811788
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.